Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ai Mogi"'
Autor:
Toshihiro Tanaka, Yuta Nakashima, Hidenori Sasaki, Michio Masaki, Ai Mogi, Kazuo Tamura, Yasushi Takamatsu
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 69-75 (2019)
Combined oral cyclophosphamide and capecitabine (XC) chemotherapy is used for metastatic breast cancer (MBC) patients. We report herein two MBC patients who developed severe hemorrhagic cystitis after XC therapy. Case 1: A 67-year-old woman with MBC
Externí odkaz:
https://doaj.org/article/19363d60330e4040958536c607cf1d3b
Autor:
Yoichiro Yoshida, Naoya Aisu, Ai Mogi, Akira Komono, Ryohei Sakamoto, Daibo Kojima, Toshiyuki Mera, Suguru Hasegawa
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 226-229 (2017)
TAS-102 significantly improves overall survival in patients with metastatic colorectal cancer. The most common adverse event of TAS-102 is bone marrow suppression, which leads to neutropenia. The incidence of neutropenia is high, and there is no know
Externí odkaz:
https://doaj.org/article/4478eeb7ec36484591b86e353ae3b72a
Autor:
Hiromi Fukuda, Kazuhide Takata, Takanori Kitaguchi, Ryo Yamauchi, Hideo Kunimoto, Takashi Tanaka, Keiji Yokoyama, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Ai Mogi, Shinichi Kora, Kaori Koga, Morishige Takeshita, Kengo Yoshimitsu, Shotaro Sakisaka
Publikováno v:
Case Reports in Hepatology, Vol 2018 (2018)
Patients with autoimmune hepatitis (AIH) may sometimes have concomitant idiopathic thrombocytopenic purpura (ITP). Severe thrombocytopenia in ITP interferes with percutaneous liver biopsy for pathological diagnosis of AIH. Here, we report a case of A
Externí odkaz:
https://doaj.org/article/b1ab4eea5cd9403481c7491a94b413d8
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77809c45efe8f7709f4208d7cf61debf
https://doi.org/10.7759/cureus.25321
https://doi.org/10.7759/cureus.25321
Autor:
Hidenori Sasaki, Ai Mogi, Yuta Nakashima, Michio Masaki, Yasushi Takamatsu, Toshihiro Tanaka, Kazuo Tamura
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 1, Pp 69-75 (2019)
Case Reports in Oncology, Vol 12, Iss 1, Pp 69-75 (2019)
Combined oral cyclophosphamide and capecitabine (XC) chemotherapy is used for metastatic breast cancer (MBC) patients. We report herein two MBC patients who developed severe hemorrhagic cystitis after XC therapy. Case 1: A 67-year-old woman with MBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd773ec416e40a41fec3f9cfcc901f5
http://europepmc.org/articles/PMC6477505
http://europepmc.org/articles/PMC6477505
Autor:
Kaori Koga, Shinichi Kora, Keiji Yokoyama, Kazuhide Takata, Takashi Tanaka, Shotaro Sakisaka, Satoshi Shakado, Ai Mogi, Yasuaki Takeyama, Takanori Kitaguchi, Kengo Yoshimitsu, Daisuke Morihara, Hideo Kunimoto, Hiromi Fukuda, Ryo Yamauchi, Morishige Takeshita
Publikováno v:
Case Reports in Hepatology
Case Reports in Hepatology, Vol 2018 (2018)
Case Reports in Hepatology, Vol 2018 (2018)
Patients with autoimmune hepatitis (AIH) may sometimes have concomitant idiopathic thrombocytopenic purpura (ITP). Severe thrombocytopenia in ITP interferes with percutaneous liver biopsy for pathological diagnosis of AIH. Here, we report a case of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11dfdca0c38c3b8ed4c2556a91956fe9
https://doi.org/10.1155/2018/5305691
https://doi.org/10.1155/2018/5305691
Autor:
Shotaro Chinen, Ai Mogi, Yasushi Takamatsu, Toshihiro Tanaka, Tohru Takata, Masanao Ishizu, Yuta Nakashima, Hidenori Sasaki
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
The safety and feasibility of oral fluoroquinolone monotherapy in patients with low-risk febrile neutropenia (FN) were demonstrated in recent studies. Levofloxacin (LVFX) is a commonly prescribed antibiotic; however, evidence for its efficacy against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1474d45e2cd4d7aa97f678f04fb870be
https://pubmed.ncbi.nlm.nih.gov/32779614
https://pubmed.ncbi.nlm.nih.gov/32779614
Autor:
Ai Mogi, Toshihiro Tanaka, Eiichi Sato, Yasushi Takamatsu, Hidenori Sasaki, Yuta Nakashima, Michio Masaki, Shotaro Chinen, Miho Ueno, Kazuo Tamura
Publikováno v:
Thoracic Cancer. 8:523-529
Background Evidence of eribulin therapy for metastatic breast cancer (MBC) in clinical practice is not well documented. Methods We retrospectively analyzed the safety and efficacy of eribulin in 29 MBC patients from 2011 to 2016 at Fukuoka University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::332069239e244dbb47354c71dfea14db
https://doi.org/10.1111/1759-7714.12482
https://doi.org/10.1111/1759-7714.12482
Autor:
Y. Naito, Michio Masaki, Yuta Nakashima, Hidenori Sasaki, Toshihiro Tanaka, Yasushi Takamatsu, Kentaro Ogata, Kazuo Tamura, Y. Ikari, Ai Mogi
Publikováno v:
International Journal of Clinical Oncology
Background Cancer chemotherapy is associated with a variety of side effects/adverse events. It is very important that patients adhere to the planned chemotherapy regimen, which necessitates a minimum of side effects and that these side effects be kep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0068239d3b375940b7180d74c53d1906
http://europepmc.org/articles/PMC5533818
http://europepmc.org/articles/PMC5533818
Autor:
Ryohei Sakamoto, Akira Komono, Toshiyuki Mera, Ai Mogi, Suguru Hasegawa, Daibo Kojima, Yoichiro Yoshida, Naoya Aisu
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 226-229 (2017)
Case Reports in Oncology
Case Reports in Oncology
TAS-102 significantly improves overall survival in patients with metastatic colorectal cancer. The most common adverse event of TAS-102 is bone marrow suppression, which leads to neutropenia. The incidence of neutropenia is high, and there is no know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f5dd4d9d8d2c136fbd104f8ed6029c
http://www.karger.com/Article/FullText/460242
http://www.karger.com/Article/FullText/460242